Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gatifloxacin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110938028B details a cost-effective, three-step synthesis of high-purity (1R)-5-bromo-2,3-dihydro-1-methyl-1H-isoindole, optimizing supply chain stability for quinolone antibiotics.